Eisler Capital Management Ltd. Buys New Holdings in Amedisys, Inc. (NASDAQ:AMED)

Eisler Capital Management Ltd. acquired a new stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 40,000 shares of the health services provider's stock, valued at approximately $3,631,000. Eisler Capital Management Ltd. owned approximately 0.12% of Amedisys as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also modified their holdings of the company. Blue Trust Inc. grew its holdings in shares of Amedisys by 55.1% in the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock valued at $34,000 after purchasing an additional 124 shares during the period. Xponance Inc. grew its stake in shares of Amedisys by 3.5% in the 4th quarter. Xponance Inc. now owns 4,349 shares of the health services provider's stock valued at $395,000 after buying an additional 148 shares during the period. Inspire Investing LLC increased its holdings in shares of Amedisys by 3.6% during the 4th quarter. Inspire Investing LLC now owns 4,405 shares of the health services provider's stock worth $400,000 after buying an additional 155 shares during the last quarter. Gamco Investors INC. ET AL increased its holdings in shares of Amedisys by 0.5% during the 4th quarter. Gamco Investors INC. ET AL now owns 30,334 shares of the health services provider's stock worth $2,754,000 after buying an additional 159 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its position in shares of Amedisys by 1.2% during the 4th quarter. Nisa Investment Advisors LLC now owns 15,150 shares of the health services provider's stock valued at $1,375,000 after buying an additional 180 shares during the period. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Stock Down 0.1%

Shares of AMED traded down $0.10 during mid-day trading on Wednesday, hitting $94.40. 151,238 shares of the company's stock were exchanged, compared to its average volume of 343,832. The stock's 50-day moving average is $93.09 and its 200-day moving average is $91.66. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. Amedisys, Inc. has a fifty-two week low of $82.15 and a fifty-two week high of $98.95. The company has a market cap of $3.10 billion, a price-to-earnings ratio of 37.46, a P/E/G ratio of 1.78 and a beta of 0.96.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, beating the consensus estimate of $1.13 by $0.12. The company had revenue of $594.78 million during the quarter, compared to analysts' expectations of $597.43 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm's revenue was up 4.1% compared to the same quarter last year. During the same quarter last year, the company posted $1.03 EPS. On average, sell-side analysts anticipate that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

AMED has been the subject of several analyst reports. Royal Bank of Canada reiterated an "outperform" rating and issued a $100.00 price objective on shares of Amedisys in a research report on Wednesday, April 16th. Stephens reaffirmed an "equal weight" rating and set a $101.00 target price on shares of Amedisys in a research note on Tuesday, March 4th. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $100.75.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.